ZBH vs. LMAT
ZBH (Zimmer Biomet Holdings, Inc.) and LMAT (LeMaitre Vascular, Inc.) are both stocks. Both are in the Healthcare sector — ZBH in Medical Devices, LMAT in Medical Instruments & Supplies. Over the past 10 years, ZBH returned -1.74%/yr vs 22.93%/yr for LMAT. At a 0.24 correlation, their price movements are largely independent.
Performance
ZBH vs. LMAT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZBH achieves a 5.19% return, which is significantly lower than LMAT's 24.25% return. Over the past 10 years, ZBH has underperformed LMAT with an annualized return of -1.74%, while LMAT has yielded a comparatively higher 22.93% annualized return.
ZBH
- 1D
- 3.00%
- 1M
- 6.50%
- 6M
- 3.43%
- YTD
- 5.19%
- 1Y
- 1.36%
- 3Y*
- -12.08%
- 5Y*
- -8.24%
- 10Y*
- -1.74%
LMAT
- 1D
- -2.38%
- 1M
- 9.06%
- 6M
- 20.21%
- YTD
- 24.25%
- 1Y
- 20.94%
- 3Y*
- 16.07%
- 5Y*
- 14.08%
- 10Y*
- 22.93%
ZBH vs. LMAT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ZBH Zimmer Biomet Holdings, Inc. | 5.19% | -14.03% | -12.46% | -3.81% | 4.24% | -17.02% | 3.77% | 45.37% | -13.30% | 17.86% |
LMAT LeMaitre Vascular, Inc. | 24.25% | -10.95% | 63.63% | 24.60% | -7.40% | 25.10% | 14.09% | 53.77% | -25.13% | 26.58% |
Correlation
The correlation between ZBH and LMAT is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.36 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.36 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.41 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2006 | 0.25 |
The correlation between ZBH and LMAT shifts across timeframes, from 0.24 (all time) to 0.41 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ZBH:
$18.20B
LMAT:
$2.29B
ZBH:
$3.85
LMAT:
$2.66
ZBH:
24.41
LMAT:
37.71
ZBH:
0.36
LMAT:
1.62
ZBH:
2.21
LMAT:
9.18
ZBH:
1.25
LMAT:
5.68
ZBH:
$8.41B
LMAT:
$256.28M
ZBH:
$5.89B
LMAT:
$185.52M
ZBH:
$2.21B
LMAT:
$90.48M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZBH vs. LMAT — Risk / Return Rank
ZBH
LMAT
ZBH vs. LMAT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZBH | LMAT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.51 | ||
| Sortino ratioReturn per unit of downside risk | -0.98 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.15 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 0.05 | 0.86 | -0.81 |
| Martin ratioReturn relative to average drawdown | 0.10 | 1.73 | -1.63 |
Loading charts...
Drawdowns
ZBH vs. LMAT - Drawdown Comparison
The maximum ZBH drawdown since its inception was -65.03%, smaller than the maximum LMAT drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for ZBH and LMAT.
Loading charts...
Drawdown Indicators
| ZBH | LMAT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.03% | -75.69% | +10.66% |
Max Drawdown (1Y)Largest decline over 1 year | -25.54% | -24.33% | -1.21% |
Max Drawdown (3Y)Largest decline over 3 years | -42.82% | -31.35% | -11.47% |
Max Drawdown (5Y)Largest decline over 5 years | -47.76% | -34.29% | -13.47% |
Max Drawdown (10Y)Largest decline over 10 years | -52.14% | -47.65% | -4.49% |
Current DrawdownCurrent decline from peak | -43.26% | -14.36% | -28.90% |
Average DrawdownAverage peak-to-trough decline | -20.16% | -18.95% | -1.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.82% | 12.11% | +1.71% |
Volatility
ZBH vs. LMAT - Volatility Comparison
Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT) have volatilities of 11.01% and 10.69%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZBH | LMAT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.01% | 10.69% | +0.32% |
Volatility (6M)Calculated over the trailing 6-month period | 22.31% | 30.88% | -8.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.94% | 37.82% | -5.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.98% | 36.57% | -9.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.61% | 41.50% | -12.89% |
Dividends
ZBH vs. LMAT - Dividend Comparison
ZBH's dividend yield for the trailing twelve months is around 1.02%, more than LMAT's 0.90% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LMAT LeMaitre Vascular, Inc. | 0.90% | 1.23% | 0.69% | 0.99% | 1.09% | 0.88% | 0.94% | 0.95% | 1.18% | 0.69% | 0.71% | 0.93% |
ZBH Zimmer Biomet Holdings, Inc. | 1.02% | 1.07% | 0.91% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% |
Financials
ZBH vs. LMAT - Financials Comparison
This section allows you to compare key financial metrics between Zimmer Biomet Holdings, Inc. and LeMaitre Vascular, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ZBH vs. LMAT - Profitability Comparison
ZBH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.51B and revenue of 2.09B. Therefore, the gross margin over that period was 72.4%.
LMAT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, LeMaitre Vascular, Inc. reported a gross profit of 48.40M and revenue of 66.55M. Therefore, the gross margin over that period was 72.7%.
ZBH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Zimmer Biomet Holdings, Inc. reported an operating income of 373.20M and revenue of 2.09B, resulting in an operating margin of 17.9%.
LMAT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, LeMaitre Vascular, Inc. reported an operating income of 17.78M and revenue of 66.55M, resulting in an operating margin of 26.7%.
ZBH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Zimmer Biomet Holdings, Inc. reported a net income of 238.10M and revenue of 2.09B, resulting in a net margin of 11.4%.
LMAT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, LeMaitre Vascular, Inc. reported a net income of 15.68M and revenue of 66.55M, resulting in a net margin of 23.6%.
Frequently Asked Questions
ZBH and LMAT have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZBH has higher volatility (11.01%) compared to LMAT (10.69%). In terms of maximum drawdown, ZBH dropped -65.03% vs LMAT's -75.69%.
LMAT currently has the higher Sharpe Ratio (0.56 vs 0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZBH and LMAT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer